Innovate UK is to invest up to £66 million capital funding to build and establish a good manufacturing practice (GMP) capable UK national vaccines development and manufacturing centre. We aim to address the UK’s structural gap in late-stage vaccine manufacturing process development. This will allow the development and manufacture of vaccines for clinical trials and, at moderate scale, for an emergency plan in case of epidemic threats to our population.
We are seeking proposals from UK organisations to lead the delivery of a new technology and innovation centre. This will focus on the development and manufacturing of new vaccines.
The centre will be based in the UK. It will have a primary focus on new vaccines and a secondary focus on the manufacture of viral vectors (gene transfers). These will be used in the development of advanced therapy medicinal products (ATMPs). It will support their development and commercialisation, as well as the underpinning technologies for their manufacture, quality control, safety and efficacy. The centre must aim to increase UK wealth by effectively commercialising such medicines and helping address companies’ and researchers’ training needs.
This competition will award funding under the government’s Industrial Strategy Challenge Fund.
Projects should last up to 3 years
and must start by 1 February 2018.